Palisade Bio to Present at the Virtual Investor Innovations in Intestinal Health - Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function Event
13.09.2022 - Live moderated video webcast with members of Management to discuss pivotal Phase 3 study of lead asset in development, LB1148, on Friday, September 16th at 11:00 AM ETCARLSBAD, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) - Palisade Bio, Inc. (Nasdaq: ... Seite 1
Source: wallstreet-online.de